Bayer AG
BAYRY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,519,073 | $33,347,602 | $47,195,276 | $45,823,385 |
| - Cash | $6,191,000 | $5,907,000 | $5,171,000 | $4,564,000 |
| + Debt | $40,697,000 | $44,789,000 | $41,646,000 | $39,531,000 |
| Enterprise Value | $53,025,073 | $72,229,602 | $83,670,276 | $80,790,385 |
| Revenue | $46,606,000 | $47,637,000 | $50,739,000 | $44,081,000 |
| % Growth | -2.2% | -6.1% | 15.1% | – |
| Gross Profit | $25,336,000 | $27,888,000 | $30,868,000 | $27,265,000 |
| % Margin | 54.4% | 58.5% | 60.8% | 61.9% |
| EBITDA | $8,807,000 | $4,209,000 | $10,443,000 | $6,968,000 |
| % Margin | 18.9% | 8.8% | 20.6% | 15.8% |
| Net Income | -$2,552,000 | -$2,941,000 | $4,150,000 | $1,000,000 |
| % Margin | -5.5% | -6.2% | 8.2% | 2.3% |
| EPS Diluted | -0.65 | -0.75 | 1.06 | 0.26 |
| % Growth | 13.3% | -170.8% | 307.7% | – |
| Operating Cash Flow | $7,368,000 | $5,117,000 | $7,093,000 | $5,089,000 |
| Capital Expenditures | -$2,778,000 | -$2,751,000 | -$2,949,000 | -$2,611,000 |
| Free Cash Flow | $4,590,000 | $2,366,000 | $4,144,000 | $2,478,000 |